EIKN — Eikon Therapeutics
Median target
$27.5
calls from the last 12 months
Implied return
+219.8%
median target vs. price
Coverage
5 analysts · 7 calls
updated in the last 12 months
Consensus
4/0/1+3 net
Buy / Hold / Sell
Which analysts are behind EIKN's consensus?
See every current rating, price target and the analysts' track records for Eikon Therapeutics — plus the full analyst rankings, firm analytics and screener.
The consensus above reflects 5 analysts with calls on EIKN updated in the last 12 months. Implied return is the move implied if the consensus target were hit. These are forward-looking predictions, not realized returns. Per-analyst ratings and track records are a Premium feature.
EIKN elsewhere on AnalystEdge
The most recent congressional, executive-branch and insider filings matched to this ticker. Matched by ticker symbol — occasional mismatches are possible. Not investment advice.
Trending today: not in any of today's trending tables (Gaining attention, Losing attention, Most followed)
| Date | Source | Who | Action | Detail | Amount |
|---|---|---|---|---|---|
| 2026-09-03 | Insiders | Column Group Iv Gp, Lp +710% owner | Insider purchase | 89.2K sh @ $11.56 | $1.0M |
More: insider activity · executive branch · trending